Fazal Khan is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of formulations for Keratinocyte Growth Factor-2 (KGF-2). With a total of 2 patents, his work focuses on therapeutic applications that promote wound healing.

Latest Patents

Fazal Khan's latest patents revolve around the innovative formulations of Keratinocyte Growth Factor-2. The inventions are directed to both liquid and lyophilized forms of KGF-2 and its derivatives. These formulations are designed for therapeutic use, specifically aimed at promoting or accelerating wound healing. The dual focus on both liquid and lyophilized forms showcases the versatility and potential impact of his work in medical treatments.

Career Highlights

Fazal Khan is associated with Human Genome Sciences, Inc., where he has been instrumental in advancing research and development in his field. His expertise in KGF-2 formulations has positioned him as a key player in the biotechnology sector. His contributions have not only enhanced the understanding of KGF-2 but also paved the way for new therapeutic strategies.

Collaborations

Fazal has collaborated with notable colleagues such as Edward J Unsworth and Thomas Spitznagel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the field.

Conclusion

Fazal Khan's work in the development of Keratinocyte Growth Factor-2 formulations exemplifies the intersection of innovation and therapeutic application. His contributions are vital for advancing wound healing treatments and reflect the importance of collaboration in scientific research.